X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10815) 10815
Newspaper Article (158) 158
Book Chapter (36) 36
Magazine Article (9) 9
Publication (6) 6
Trade Publication Article (4) 4
Book / eBook (2) 2
Book Review (2) 2
Conference Proceeding (2) 2
Dissertation (1) 1
Newsletter (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9441) 9441
male (6039) 6039
female (5714) 5714
catheter ablation - adverse effects (5534) 5534
cardiac & cardiovascular systems (5110) 5110
middle aged (4973) 4973
catheter ablation (4526) 4526
treatment outcome (4340) 4340
aged (4005) 4005
catheter ablation - methods (3409) 3409
ablation (3328) 3328
atrial fibrillation (3008) 3008
adult (2640) 2640
atrial fibrillation - surgery (2575) 2575
radiofrequency ablation (2219) 2219
risk factors (1705) 1705
time factors (1647) 1647
surgery (1600) 1600
retrospective studies (1488) 1488
catheters (1462) 1462
follow-up studies (1428) 1428
recurrence (1406) 1406
electrocardiography (1255) 1255
atrial fibrillation - physiopathology (1242) 1242
care and treatment (1194) 1194
cardiac arrhythmia (1180) 1180
medicine & public health (1056) 1056
atrial fibrillation - diagnosis (1038) 1038
aged, 80 and over (1037) 1037
cardiology (1027) 1027
prospective studies (1020) 1020
cardiovascular (1005) 1005
pulmonary vein isolation (943) 943
pulmonary veins - surgery (929) 929
management (922) 922
catheter ablation - instrumentation (890) 890
animals (874) 874
radiofrequency catheter ablation (862) 862
tachycardia (831) 831
liver neoplasms - surgery (820) 820
complications (816) 816
abridged index medicus (808) 808
radiology, nuclear medicine & medical imaging (806) 806
patients (804) 804
analysis (780) 780
fibrillation (753) 753
risk assessment (737) 737
follow-up (726) 726
heart (710) 710
efficacy (701) 701
safety (701) 701
anti-arrhythmia agents - therapeutic use (679) 679
atrial fibrillation - therapy (668) 668
therapy (667) 667
peripheral vascular disease (641) 641
adolescent (640) 640
tomography, x-ray computed (625) 625
cancer (603) 603
arrhythmia (599) 599
risk (595) 595
mortality (586) 586
equipment design (577) 577
electrophysiologic techniques, cardiac (545) 545
gastroenterology & hepatology (539) 539
stroke (536) 536
carcinoma, hepatocellular - surgery (530) 530
tumors (530) 530
atrial-fibrillation (524) 524
prognosis (519) 519
predictive value of tests (497) 497
atrial fibrillation - complications (489) 489
health aspects (474) 474
engineering, biomedical (451) 451
oncology (446) 446
outcomes (445) 445
young adult (443) 443
trial (432) 432
thermal ablation (428) 428
medicine, general & internal (426) 426
feasibility studies (423) 423
hepatocellular carcinoma (422) 422
kaplan-meier estimate (417) 417
child (416) 416
liver neoplasms - pathology (414) 414
heart failure (408) 408
incidence (408) 408
arrhythmias (406) 406
heart rate (405) 405
echocardiography (401) 401
pulmonary veins - physiopathology (395) 395
quality of life (395) 395
radiofrequency (395) 395
heart conduction system - surgery (374) 374
tachycardia, ventricular - surgery (374) 374
prevalence (372) 372
liver neoplasms - therapy (371) 371
ventricular tachycardia (371) 371
magnetic resonance imaging (370) 370
cryosurgery - adverse effects (366) 366
electrophysiology (366) 366
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10668) 10668
Japanese (117) 117
German (113) 113
French (88) 88
Spanish (69) 69
Chinese (58) 58
Portuguese (30) 30
Russian (30) 30
Italian (26) 26
Polish (19) 19
Danish (15) 15
Czech (12) 12
Norwegian (9) 9
Swedish (9) 9
Hungarian (5) 5
Korean (5) 5
Dutch (4) 4
Finnish (4) 4
Hebrew (3) 3
Romanian (2) 2
Slovak (2) 2
Turkish (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Calkins, Hugh and Hindricks, Gerhard and Cappato, Riccardo and Kim, Young-Hoon and Saad, Eduardo B and Aguinaga, Luis and Akar, Joseph G and Badhwar, Vinay and Brugada, Josep and Camm, John and Chen, Peng-Sheng and Chen, Shih-Ann and Chung, Mina K and Cosedis Nielsen, Jens and Curtis, Anne B and Davies, D Wyn and Day, John D and d’Avila, André and (Natasja) de Groot, N M S and Di Biase, Luigi and Duytschaever, Mattias and Edgerton, James R and Ellenbogen, Kenneth A and Ellinor, Patrick T and Ernst, Sabine and Fenelon, Guilherme and Gerstenfeld, Edward P and Haines, David E and Haissaguerre, Michel and Helm, Robert H and Hylek, Elaine and Jackman, Warren M and Jalife, Jose and Kalman, Jonathan M and Kautzner, Josef and Kottkamp, Hans and Kuck, Karl Heinz and Kumagai, Koichiro and Lee, Richard and Lewalter, Thorsten and Lindsay, Bruce D and Macle, Laurent and Mansour, Moussa and Marchlinski, Francis E and Michaud, Gregory F and Nakagawa, Hiroshi and Natale, Andrea and Nattel, Stanley and Okumura, Ken and Packer, Douglas and Pokushalov, Evgeny and Reynolds, Matthew R and Sanders, Prashanthan and Scanavacca, Mauricio and Schilling, Richard and Tondo, Claudio and Tsao, Hsuan-Ming and Verma, Atul and Wilber, David J and Yamane, Teiichi and Blomström-Lundqvist, Carina and De Paola, Angelo A V and Kistler, Peter M and Lip, Gregory Y H and Peters, Nicholas S and Pisani, Cristiano F and Raviele, Antonio and Saad, Eduardo B and Satomi, Kazuhiro and Stiles, Martin K and Willems, Stephan and Document Reviewers and JHRS and Soc Latinoamer Estimulacion and APHRS and Soc Brasileira Arritmias Cardiacas and EHRA and AHA and STS and ACC and ECAS and CHRS
Europace (London, England), ISSN 1532-2092, 2018, Volume 20, Issue 1, pp. e1 - e160
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
.... This trial was designed to assess the efficacy and safety of sorafenib versus placebo as adjuvant therapy in patients with hepatocellular carcinoma after surgical resection or local ablation... 
Hematology, Oncology and Palliative Medicine | CLINICAL-PRACTICE GUIDELINES | DIAGNOSIS | LIVER-TRANSPLANTATION | RISK-FACTORS | THERAPY | MANAGEMENT | ONCOLOGY | SAFETY | PREVENTION | RECURRENCE | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents
Journal Article